Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
EDMONTON, Alberta, Oct. 22, 2019 (GLOBE NEWSWIRE) -- Radient Technologies Inc. (“Radient” or the “Company”) (TSX Venture: RTI; OTCQX: RDDTF), a global commercial manufacturer of high-quality...
-
LOS ANGELES, Oct. 17, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that the results of a preclinical study conducted by Nestlé were published last month in the journal...
-
ANAHEIM, Calif., Oct. 16, 2019 (GLOBE NEWSWIRE) -- Bridgford Foods Corporation (Nasdaq: BRID) today announced that Paul R. Zippwald resigned as a member of the Board of Directors of Bridgford Foods...
-
LOS ANGELES, Oct. 07, 2019 (GLOBE NEWSWIRE) -- Dr. Charles Brenner, the Roy J. Carver Chair and Head of Biochemistry at the University of Iowa, receives a research grant from the Bill & Melinda...
-
HOUSTON, Oct. 04, 2019 (GLOBE NEWSWIRE) -- Sysco Corporation (NYSE: SYY), the leading global foodservice distribution company, announced the availability of nine new products exclusively for...
-
New York, Sept. 10, 2019 (GLOBE NEWSWIRE) -- Increasing demand for aluminum caps & closures in reusable sub-segment coupled with high investment in R&D of aluminum caps & closures is...
-
LOS ANGELES, Aug. 14, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that it has entered into a securities purchase agreement for the sale of $7.0 million of its common stock...
-
Los Angeles, Aug. 13, 2019 (GLOBE NEWSWIRE) -- Giggles N’ Hugs, Inc. (OTCQB: GIGL), owner and operator of family-friendly restaurants that bring together high-end, organic food with active,...
-
LOS ANGELES, July 24, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today its flagship consumer product, Tru Niagen® (nicotinamide riboside) is now available in all seven Whole...
-
LOS ANGELES, July 08, 2019 (GLOBE NEWSWIRE) -- ChromaDex Corp. (NASDAQ:CDXC) announced today that the results of its latest clinical study were published Friday in the journal Scientific Reports....